{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:33:49Z","timestamp":1795199629569,"version":"4.10.3"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","award":["NMRC\/OFIRG\/0040\/2017"],"award-info":[{"award-number":["NMRC\/OFIRG\/0040\/2017"]}],"id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/MOHIAFCAT2\/004\/2015"],"award-info":[{"award-number":["NMRC\/MOHIAFCAT2\/004\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41596-020-0310-z","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T12:56:37Z","timestamp":1587992197000},"page":"1881-1921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Cellular thermal shift assay for the identification of drug\u2013target interactions in the Plasmodium falciparum proteome"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-0395","authenticated-orcid":false,"given":"Jerzy Michal","family":"Dziekan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6858-8547","authenticated-orcid":false,"given":"Grennady","family":"Wirjanata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-5967","authenticated-orcid":false,"given":"Lingyun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1782-2775","authenticated-orcid":false,"given":"Ka Diam","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Ting","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-0296","authenticated-orcid":false,"given":"Liyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loo Chien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Puspita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2350-6552","authenticated-orcid":false,"given":"Nayana","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-2526","authenticated-orcid":false,"given":"Radoslaw M.","family":"Sobota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-702X","authenticated-orcid":false,"given":"P\u00e4r","family":"Nordlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-8446","authenticated-orcid":false,"given":"Zbynek","family":"Bozdech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"310_CR1","unstructured":"World Health Organization. World Malaria Report 2019 (2019)."},{"key":"310_CR2","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/AAC.00835-15","volume":"59","author":"R Leang","year":"2015","unstructured":"Leang, R. et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob. Agents Chemother. 59, 4719\u20134726 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"310_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455\u2013467 (2009).","journal-title":"N. Engl. J. Med."},{"key":"310_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","volume":"12","author":"C Amaratunga","year":"2012","unstructured":"Amaratunga, C. et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect. Dis. 12, 851\u2013858 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"310_CR5","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/AAC.02746-14","volume":"58","author":"K Thriemer","year":"2014","unstructured":"Thriemer, K. et al. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrob. Agents Chemother. 58, 7049\u20137055 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"310_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/ciw388","volume":"63","author":"AP Phyo","year":"2016","unstructured":"Phyo, A. P. et al. Declining efficacy of artemisinin combination therapy against P. Falciparum malaria on the Thai-Myanmar border (2003-2013): the role of parasite genetic factors. Clin. Infect. Dis. 63, 784\u2013791 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"310_CR7","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2217\/fmb.10.136","volume":"5","author":"IB Muller","year":"2010","unstructured":"Muller, I. B. & Hyde, J. E. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol. 5, 1857\u20131873 (2010).","journal-title":"Future Microbiol."},{"key":"310_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/cmdc.200600240","volume":"2","author":"M Schlitzer","year":"2007","unstructured":"Schlitzer, M. Malaria chemotherapeutics part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development. ChemMedChem. 2, 944\u2013986 (2007).","journal-title":"ChemMedChem."},{"key":"310_CR9","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1038\/ncomms11901","volume":"7","author":"VC Corey","year":"2016","unstructured":"Corey, V. C. et al. A broad analysis of resistance development in the malaria parasite. Nat. Commun. 7, 11901 (2016).","journal-title":"Nat. Commun."},{"key":"310_CR10","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.1021\/jm400325j","volume":"56","author":"EL Flannery","year":"2013","unstructured":"Flannery, E. L., Fidock, D. A. & Winzeler, E. A. Using genetic methods to define the targets of compounds with antimalarial activity. J. Med. Chem. 56, 7761\u20137771 (2013).","journal-title":"J. Med. Chem."},{"key":"310_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep15930","volume":"5","author":"A Pradhan","year":"2015","unstructured":"Pradhan, A. et al. Chemogenomic profiling of Plasmodium falciparum as a tool to aid antimalarial drug discovery. Sci. Rep. 5, 15930 (2015).","journal-title":"Sci. Rep."},{"key":"310_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nbt.1597","volume":"28","author":"G Hu","year":"2010","unstructured":"Hu, G. et al. Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Nat. Biotechnol. 28, 91\u201398 (2010).","journal-title":"Nat. Biotechnol."},{"key":"310_CR13","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1073\/pnas.1600459113","volume":"113","author":"HM Ismail","year":"2016","unstructured":"Ismail, H. M. et al. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7. Proc. Natl Acad. Sci. USA 113, 2080\u20132085 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR14","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1128\/AAC.01224-16","volume":"60","author":"EL Allman","year":"2016","unstructured":"Allman, E. L., Painter, H. J., Samra, J., Carrasquilla, M. & Llinas, M. Metabolomic profiling of the malaria box reveals antimalarial target pathways. Antimicrob. Agents Chemother. 60, 6635\u20136649 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"310_CR15","doi-asserted-by":"publisher","first-page":"6650","DOI":"10.1128\/AAC.01226-16","volume":"60","author":"DJ Creek","year":"2016","unstructured":"Creek, D. J. et al. Metabolomics-based screening of the malaria box reveals both novel and established mechanisms of action. Antimicrob. Agents Chemother. 60, 6650\u20136663 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"310_CR16","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.12688\/f1000research.9477.1","volume":"5","author":"RL Edwards","year":"2016","unstructured":"Edwards, R. L. & Odom John, A. R. Muddled mechanisms: recent progress towards antimalarial target identification. F1000Res. 5, 2514 (2016).","journal-title":"F1000Res."},{"key":"310_CR17","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100\u20132122 (2014).","journal-title":"Nat. Protoc."},{"key":"310_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387 (2013).","journal-title":"Science"},{"key":"310_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","volume":"56","author":"D Martinez Molina","year":"2016","unstructured":"Martinez Molina, D. & Nordlund, P. The cellular thermal shift assay: a novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies. Annu. Rev. Pharmacol. Toxicol. 56, 141\u2013161 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"310_CR20","doi-asserted-by":"publisher","first-page":"1255784","DOI":"10.1126\/science.1255784","volume":"346","author":"MM Savitski","year":"2014","unstructured":"Savitski, M. M. et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science 346, 1255784 (2014).","journal-title":"Science"},{"key":"310_CR21","doi-asserted-by":"publisher","first-page":"eaau3174","DOI":"10.1126\/scitranslmed.aau3174","volume":"11","author":"JM Dziekan","year":"2019","unstructured":"Dziekan, J. M. et al. Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay. Sci. Transl. Med. 11, eaau3174 (2019).","journal-title":"Sci. Transl. Med."},{"key":"310_CR22","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nprot.2015.101","volume":"10","author":"H Franken","year":"2015","unstructured":"Franken, H. et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat. Protoc. 10, 1567\u20131593 (2015).","journal-title":"Nat. Protoc."},{"key":"310_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood-2005-11-007799","volume":"108","author":"EM Pasini","year":"2006","unstructured":"Pasini, E. M. et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108, 791\u2013801 (2006).","journal-title":"Blood"},{"key":"310_CR24","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1021\/pr8001029","volume":"7","author":"JH Ringrose","year":"2008","unstructured":"Ringrose, J. H. et al. Highly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramatically. J. Proteome Res. 7, 3060\u20133063 (2008).","journal-title":"J. Proteome Res."},{"key":"310_CR25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/elps.201000659","volume":"32","author":"GM D\u2019Amici","year":"2011","unstructured":"D\u2019Amici, G. M., Rinalducci, S. & Zolla, L. An easy preparative gel electrophoretic method for targeted depletion of hemoglobin in erythrocyte cytosolic samples. Electrophoresis 32, 1319\u20131322 (2011).","journal-title":"Electrophoresis"},{"key":"310_CR26","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1074\/mcp.M800037-MCP200","volume":"7","author":"F Roux-Dalvai","year":"2008","unstructured":"Roux-Dalvai, F. et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol. Cell. Proteomics 7, 2254\u20132269 (2008).","journal-title":"Mol. Cell. Proteomics"},{"key":"310_CR27","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/elps.201200151","volume":"33","author":"K Walpurgis","year":"2012","unstructured":"Walpurgis, K. et al. Validated hemoglobin-depletion approach for red blood cell lysate proteome analysis by means of 2D PAGE and Orbitrap MS. Electrophoresis 33, 2537\u20132545 (2012).","journal-title":"Electrophoresis"},{"key":"310_CR28","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1021\/acs.analchem.8b00600","volume":"90","author":"F Klont","year":"2018","unstructured":"Klont, F. et al. Assessment of sample preparation bias in mass spectrometry-based proteomics. Anal. Chem. 90, 5405\u20135413 (2018).","journal-title":"Anal. Chem."},{"key":"310_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2472555218813332","volume":"24","author":"J Shaw","year":"2019","unstructured":"Shaw, J. et al. Positioning high-throughput CETSA in early drug discovery through screening against B-Raf and PARP1. SLAS Discovery 24, 121\u2013132 (2019).","journal-title":"SLAS Discovery"},{"key":"310_CR30","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1021\/acs.jmedchem.8b00270","volume":"61","author":"SM Yang","year":"2018","unstructured":"Yang, S. M. et al. Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity. J. Med. Chem. 61, 4883\u20134903 (2018).","journal-title":"J. Med. Chem."},{"key":"310_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41467-017-02293-7","volume":"9","author":"BDG Page","year":"2018","unstructured":"Page, B. D. G. et al. Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells. Nat. Commun. 9, 250 (2018).","journal-title":"Nat. Commun."},{"key":"310_CR32","doi-asserted-by":"publisher","first-page":"13000","DOI":"10.1038\/s41598-017-12513-1","volume":"7","author":"T Ishii","year":"2017","unstructured":"Ishii, T. et al. CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens. Scientific Rep. 7, 13000 (2017).","journal-title":"Scientific Rep."},{"key":"310_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nmeth.3652","volume":"12","author":"FB Reinhard","year":"2015","unstructured":"Reinhard, F. B. et al. Thermal proteome profiling monitors ligand interactions with cellular membrane proteins. Nat. Methods 12, 1129\u20131131 (2015).","journal-title":"Nat. Methods"},{"key":"310_CR34","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41467-017-02287-5","volume":"8","author":"M Kitagawa","year":"2017","unstructured":"Kitagawa, M. et al. Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality. Nat. Commun. 8, 2200 (2017).","journal-title":"Nat. Commun."},{"key":"310_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","volume":"5","author":"V Corpas-Lopez","year":"2019","unstructured":"Corpas-Lopez, V. et al. Pharmacological validation of N-myristoyltransferase as a drug target in Leishmania donovani. ACS Infect. Dis. 5, 111\u2013122 (2019).","journal-title":"ACS Infect. Dis."},{"key":"310_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.1199","volume":"9","author":"M Schenone","year":"2013","unstructured":"Schenone, M., Dancik, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232\u2013240 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"310_CR37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nchembio.2185","volume":"12","author":"I Becher","year":"2016","unstructured":"Becher, I. et al. Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat. Nat. Chem. Biol. 12, 908\u2013910 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"310_CR38","doi-asserted-by":"publisher","first-page":"e0208273","DOI":"10.1371\/journal.pone.0208273","volume":"13","author":"YT Lim","year":"2018","unstructured":"Lim, Y. T. et al. An efficient proteome-wide strategy for discovery and characterization of cellular nucleotide-protein interactions. PLoS One 13, e0208273 (2018).","journal-title":"PLoS One"},{"key":"310_CR39","unstructured":"Dai, L. et al. Horizontal cell biology: monitoring global changes of protein interaction states with the proteome-wide cellular thermal shift assay (CETSA). Annu. Rev. Biochem. 88, 383-408 (2019)."},{"key":"310_CR40","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nmeth.3590","volume":"12","author":"KV Huber","year":"2015","unstructured":"Huber, K. V. et al. Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling. Nat. Methods 12, 1055\u20131057 (2015).","journal-title":"Nat. Methods"},{"key":"310_CR41","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1126\/science.aan0346","volume":"359","author":"CSH Tan","year":"2018","unstructured":"Tan, C. S. H. et al. Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells. Science 359, 1170\u20131177 (2018).","journal-title":"Science"},{"key":"310_CR42","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2018.03.065","volume":"173","author":"L Dai","year":"2018","unstructured":"Dai, L. et al. Modulation of protein-interaction states through the cell cycle. Cell 173, 1481\u20131494.e1413 (2018).","journal-title":"Cell"},{"key":"310_CR43","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2018.03.053","volume":"173","author":"I Becher","year":"2018","unstructured":"Becher, I. et al. Pervasive protein thermal stability variation during the cell cycle. Cell 173, 1495\u20131507.e1418 (2018).","journal-title":"Cell"},{"key":"310_CR44","doi-asserted-by":"publisher","first-page":"101168","DOI":"10.1016\/j.redox.2019.101168","volume":"24","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA. Redox Biol. 24, 101168 (2019).","journal-title":"Redox Biol."},{"key":"310_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10495-016-1265-y","volume":"21","author":"S Gunjan","year":"2016","unstructured":"Gunjan, S. et al. Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium. Apoptosis 21, 955\u2013964 (2016).","journal-title":"Apoptosis"},{"key":"310_CR46","doi-asserted-by":"publisher","first-page":"e1006930","DOI":"10.1371\/journal.ppat.1006930","volume":"14","author":"F Rocamora","year":"2018","unstructured":"Rocamora, F. et al. Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog. 14, e1006930 (2018).","journal-title":"PLoS Pathog."},{"key":"310_CR47","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","volume":"9","author":"JL Bridgford","year":"2018","unstructured":"Bridgford, J. L. et al. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat. Commun. 9, 3801 (2018).","journal-title":"Nat. Commun."},{"key":"310_CR48","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","volume":"32","author":"SR Meshnick","year":"2002","unstructured":"Meshnick, S. R. Artemisinin: mechanisms of action, resistance and toxicity. Int. J. Parasitol. 32, 1655\u20131660 (2002).","journal-title":"Int. J. Parasitol."},{"key":"310_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","volume":"93","author":"L Cui","year":"2015","unstructured":"Cui, L., Mharakurwa, S., Ndiaye, D., Rathod, P. K. & Rosenthal, P. J. Antimalarial drug resistance: literature review and activities and findings of the ICEMR Network. Am. J. Trop. Med. Hyg. 93, 57\u201368 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"310_CR50","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1038\/ncomms5029","volume":"5","author":"D Birth","year":"2014","unstructured":"Birth, D., Kao, W. C. & Hunte, C. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action. Nat. Commun. 5, 4029 (2014).","journal-title":"Nat. Commun."},{"key":"310_CR51","doi-asserted-by":"publisher","first-page":"E1759","DOI":"10.1073\/pnas.1322965111","volume":"111","author":"RL Summers","year":"2014","unstructured":"Summers, R. L. et al. Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite\u2019s chloroquine resistance transporter. Proc. Natl Acad. Sci. USA 111, E1759\u2013E1767 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MOH.0b013e3280f31b2d","volume":"14","author":"K Haldar","year":"2007","unstructured":"Haldar, K. & Mohandas, N. Erythrocyte remodeling by malaria parasites. Curr. Opin. Hematol. 14, 203\u2013209 (2007).","journal-title":"Curr. Opin. Hematol."},{"key":"310_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrmicro2110","volume":"7","author":"AG Maier","year":"2009","unstructured":"Maier, A. G., Cooke, B. M., Cowman, A. F. & Tilley, L. Malaria parasite proteins that remodel the host erythrocyte. Nat. Rev. Microbiol. 7, 341\u2013354 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"310_CR54","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2141.2011.08755.x","volume":"154","author":"CA Moxon","year":"2011","unstructured":"Moxon, C. A., Grau, G. E. & Craig, A. G. Malaria: modification of the red blood cell and consequences in the human host. Br. J. Haematol. 154, 670\u2013679 (2011).","journal-title":"Br. J. Haematol."},{"key":"310_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","volume":"4","author":"MR Luth","year":"2018","unstructured":"Luth, M. R., Gupta, P., Ottilie, S. & Winzeler, E. A. Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery. ACS Infect. Dis. 4, 301\u2013314 (2018).","journal-title":"ACS Infect. Dis."},{"key":"310_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1126\/science.aan4472","volume":"359","author":"AN Cowell","year":"2018","unstructured":"Cowell, A. N. et al. Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics. Science 359, 191\u2013199 (2018).","journal-title":"Science"},{"key":"310_CR57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baragana","year":"2015","unstructured":"Baragana, B. et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522, 315\u2013320 (2015).","journal-title":"Nature"},{"key":"310_CR58","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","volume":"11","author":"D Hoepfner","year":"2012","unstructured":"Hoepfner, D. et al. Selective and specific inhibition of the Plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin. Cell Host Microbe 11, 654\u2013663 (2012).","journal-title":"Cell Host Microbe"},{"key":"310_CR59","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1073\/pnas.1011560108","volume":"108","author":"ES Istvan","year":"2011","unstructured":"Istvan, E. S. et al. Validation of isoleucine utilization targets in I. Proc. Natl Acad. Sci. USA 108, 1627\u20131632 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR60","doi-asserted-by":"publisher","first-page":"288ra277","DOI":"10.1126\/scitranslmed.aaa3575","volume":"7","author":"JD Herman","year":"2015","unstructured":"Herman, J. D. et al. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs. Sci. Transl. Med. 7, 288ra277 (2015).","journal-title":"Sci. Transl. Med."},{"key":"310_CR61","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1073\/pnas.1320886110","volume":"111","author":"AK Lukens","year":"2014","unstructured":"Lukens, A. K. et al. Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance. Proc. Natl Acad. Sci. USA 111, 799\u2013804 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR62","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175\u20131180 (2010).","journal-title":"Science"},{"key":"310_CR63","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1038\/ncomms6521","volume":"5","author":"AB Vaidya","year":"2014","unstructured":"Vaidya, A. B. et al. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum. Nat. Commun. 5, 5521 (2014).","journal-title":"Nat. Commun."},{"key":"310_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/cb500616x","volume":"10","author":"EL Flannery","year":"2015","unstructured":"Flannery, E. L. et al. Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. ACS Chem. Biol. 10, 413\u2013420 (2015).","journal-title":"ACS Chem. Biol."},{"key":"310_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0673-3","volume":"11","author":"AN Cowell","year":"2019","unstructured":"Cowell, A. N. & Winzeler, E. A. Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections. Genome Med. 11, 63 (2019).","journal-title":"Genome Med."},{"key":"310_CR66","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1128\/AAC.02727-13","volume":"58","author":"KL Kuhen","year":"2014","unstructured":"Kuhen, K. L. et al. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrob. Agents Chemother. 58, 5060\u20135067 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"310_CR67","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.tibtech.2018.06.008","volume":"36","author":"G Drewes","year":"2018","unstructured":"Drewes, G. & Knapp, S. Chemoproteomics and chemical probes for target discovery. Trends Biotechnol. 36, 1275\u20131286 (2018).","journal-title":"Trends Biotechnol."},{"key":"310_CR68","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1073\/pnas.0900191106","volume":"106","author":"SE Ong","year":"2009","unstructured":"Ong, S. E. et al. Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc. Natl Acad. Sci. USA 106, 4617\u20134622 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR69","doi-asserted-by":"publisher","first-page":"10111","DOI":"10.1038\/ncomms10111","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Haem-activated promiscuous targeting of artemisinin in I. Nat. Commun. 6, 10111 (2015).","journal-title":"Nat. Commun."},{"key":"310_CR70","doi-asserted-by":"publisher","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","volume":"9","author":"T Paquet","year":"2017","unstructured":"Paquet, T. et al. Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci. Transl. Med. 9, eaad9735 (2017).","journal-title":"Sci. Transl. Med."},{"key":"310_CR71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","volume":"1263","author":"MY Pai","year":"2015","unstructured":"Pai, M. Y. et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol. Biol. 1263, 287\u2013298 (2015).","journal-title":"Methods Mol. Biol."},{"key":"310_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/srep03743","volume":"4","author":"W Sun","year":"2014","unstructured":"Sun, W. et al. Chemical signatures and new drug targets for gametocytocidal drug development. Sci. Rep. 4, 3743 (2014).","journal-title":"Sci. Rep."},{"key":"310_CR73","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick, B. et al. Target identification using drug affinity responsive target stability (DARTS). Proc. Natl Acad. Sci. USA 106, 21984\u201321989 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-2165-1","volume":"16","author":"GH Siwo","year":"2015","unstructured":"Siwo, G. H. et al. An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum. BMC Genomics 16, 1030 (2015).","journal-title":"BMC Genomics"},{"key":"310_CR75","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0006-2952(01)00878-4","volume":"63","author":"O Famin","year":"2002","unstructured":"Famin, O. & Ginsburg, H. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum\u2013infected erythrocytes. Biochem. Pharmacol. 63, 393\u2013398 (2002).","journal-title":"Biochem. Pharmacol."},{"key":"310_CR76","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/0006-2952(86)90473-9","volume":"35","author":"S Zarchin","year":"1986","unstructured":"Zarchin, S., Krugliak, M. & Ginsburg, H. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials. Biochem. Pharmacol. 35, 2435\u20132442 (1986).","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 2","key":"310_CR77","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/bj3390363","volume":"339","author":"P Loria","year":"1999","unstructured":"Loria, P., Miller, S., Foley, M. & Tilley, L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem. J. 339(Pt 2), 363\u2013370 (1999).","journal-title":"Biochem. J."},{"key":"310_CR78","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1128\/AAC.01881-12","volume":"57","author":"DW Wilson","year":"2013","unstructured":"Wilson, D. W., Langer, C., Goodman, C. D., McFadden, G. I. & Beeson, J. G. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob. Agents Chemother. 57, 1455\u20131467 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"310_CR79","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","volume":"32","author":"L Tilley","year":"2016","unstructured":"Tilley, L., Straimer, J., Gnadig, N. F., Ralph, S. A. & Fidock, D. A. Artemisinin action and resistance in Plasmodium falciparum. Trends Parasitol. 32, 682\u2013696 (2016).","journal-title":"Trends Parasitol."},{"key":"310_CR80","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/nprot.2016.096","volume":"11","author":"MJ Delves","year":"2016","unstructured":"Delves, M. J. et al. Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions. Nat. Protoc. 11, 1668\u20131680 (2016).","journal-title":"Nat. Protoc."},{"key":"310_CR81","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nprot.2016.056","volume":"11","author":"S Duffy","year":"2016","unstructured":"Duffy, S., Loganathan, S., Holleran, J. P. & Avery, V. M. Large-scale production of Plasmodium falciparum gametocytes for malaria drug discovery. Nat. Protoc. 11, 976\u2013992 (2016).","journal-title":"Nat. Protoc."},{"key":"310_CR82","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","volume":"17","author":"SA Mikolajczak","year":"2015","unstructured":"Mikolajczak, S. A. et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 17, 526\u2013535 (2015).","journal-title":"Cell Host Microbe"},{"key":"310_CR83","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1073\/pnas.1217452110","volume":"110","author":"N Klonis","year":"2013","unstructured":"Klonis, N. et al. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc. Natl Acad. Sci. USA 110, 5157\u20135162 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"310_CR84","doi-asserted-by":"publisher","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","volume":"13","author":"C Dogovski","year":"2015","unstructured":"Dogovski, C. et al. Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance. PLoS Biol. 13, e1002132 (2015).","journal-title":"PLoS Biol."},{"key":"310_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/srep26212","volume":"6","author":"M Inyushin","year":"2016","unstructured":"Inyushin, M. et al. Superparamagnetic properties of hemozoin. Sci. Rep. 6, 26212 (2016).","journal-title":"Sci. Rep."},{"key":"310_CR86","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/BJ20061725","volume":"403","author":"KE Jackson","year":"2007","unstructured":"Jackson, K. E. et al. Selective permeabilization of the host cell membrane of I-infected red blood cells with streptolysin O and equinatoxin II. Biochem. J. 403, 167\u2013175 (2007).","journal-title":"Biochem. J."},{"key":"310_CR87","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ymeth.2007.01.007","volume":"41","author":"GG Prive","year":"2007","unstructured":"Prive, G. G. Detergents for the stabilization and crystallization of membrane proteins. Methods 41, 388\u2013397 (2007).","journal-title":"Methods"},{"key":"310_CR88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.str.2008.02.004","volume":"16","author":"AI Alexandrov","year":"2008","unstructured":"Alexandrov, A. I., Mileni, M., Chien, E. Y., Hanson, M. A. & Stevens, R. C. Microscale fluorescent thermal stability assay for membrane proteins. Structure 16, 351\u2013359 (2008).","journal-title":"Structure"},{"key":"310_CR89","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nsmb.2860","volume":"21","author":"F Guettou","year":"2014","unstructured":"Guettou, F. et al. Selectivity mechanism of a bacterial homolog of the human drug-peptide transporters PepT1 and PepT2. Nat. Struct. Mol. Biol. 21, 728\u2013731 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"310_CR90","unstructured":"Kawatkar, A. et al. CETSA beyond soluble targets: a broad application to multipass transmembrane proteins. ACS Chem. Biol. 14, 1913-1920 (2019)."},{"key":"310_CR91","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde, A. et al. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344, 257\u2013263 (2001).","journal-title":"N. Engl. J. Med."},{"key":"310_CR92","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price, R. N. et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438\u2013447 (2004).","journal-title":"Lancet"},{"key":"310_CR93","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/infdis\/jis691","volume":"207","author":"A Kone","year":"2013","unstructured":"Kone, A. et al. Quinine treatment selects the pfnhe-1 ms4760-1 polymorphism in Malian patients with Falciparum malaria. J. Infect. Dis. 207, 520\u2013527 (2013).","journal-title":"J. Infect. Dis."},{"key":"310_CR94","first-page":"8","volume":"3","author":"D Menard","year":"2013","unstructured":"Menard, D. et al. Global analysis of Plasmodium falciparum Na(+)\/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine. Int. J. Parasitol. 3, 8\u201319 (2013).","journal-title":"Int. J. Parasitol."},{"key":"310_CR95","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/mmi.12505","volume":"91","author":"S Mok","year":"2014","unstructured":"Mok, S. et al. Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs. Mol. Microbiol. 91, 918\u2013934 (2014).","journal-title":"Mol. Microbiol."},{"key":"310_CR96","doi-asserted-by":"publisher","first-page":"36336","DOI":"10.1074\/jbc.M114.614206","volume":"289","author":"S Bellanca","year":"2014","unstructured":"Bellanca, S. et al. Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites. J. Biol. Chem. 289, 36336\u201336351 (2014).","journal-title":"J. Biol. Chem."},{"key":"310_CR97","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2958.2007.05664.x","volume":"64","author":"CP Sanchez","year":"2007","unstructured":"Sanchez, C. P. et al. Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol. Microbiol. 64, 407\u2013420 (2007).","journal-title":"Mol. Microbiol."},{"key":"310_CR98","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1021\/bi034269h","volume":"42","author":"CP Sanchez","year":"2003","unstructured":"Sanchez, C. P., Stein, W. & Lanzer, M. Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry 42, 9383\u20139394 (2003).","journal-title":"Biochemistry"},{"key":"310_CR99","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/00034983.1939.11685064","volume":"33","author":"SR Christophers","year":"1939","unstructured":"Christophers, S. R. & Fulton, J. D. Experiments with isolated malaria parasites (Plasmodium knowlesi) free from red cells. Ann. Trop. Med. Parasitol. 33, 161\u2013170 (1939).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"310_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-45","volume":"7","author":"C Ribaut","year":"2008","unstructured":"Ribaut, C. et al. Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malar. J. 7, 45 (2008).","journal-title":"Malar. J."},{"key":"310_CR101","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1529\/biophysj.108.134973","volume":"95","author":"P Cimmperman","year":"2008","unstructured":"Cimmperman, P. et al. A quantitative model of thermal stabilization and destabilization of proteins by ligands. Biophys. J. 95, 3222\u20133231 (2008).","journal-title":"Biophys. J."},{"key":"310_CR102","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"310_CR103","unstructured":"Zecha, J. et al. TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach. Mol. Cell. Proteomics 18, 1468-1478 (2019)."},{"key":"310_CR104","unstructured":"Childs, D. et al. TPP: Analyze Thermal Proteome Profiling (TPP) Experiments. R package version 3.14.0 http:\/\/bioconductor.org\/packages\/release\/bioc\/html\/TPP.html (2019)."},{"key":"310_CR105","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1074\/mcp.TIR119.001481","volume":"18","author":"D Childs","year":"2019","unstructured":"Childs, D. et al. Nonparametric analysis of thermal proteome profiles reveals novel drug-binding proteins. Mol. Cell. Proteomics 18, 2506\u20132515 (2019).","journal-title":"Mol. Cell. Proteomics"},{"key":"310_CR106","doi-asserted-by":"crossref","unstructured":"Borras, E. & Sabido, E. What is targeted proteomics? A concise revision of targeted acquisition and targeted data analysis in mass spectrometry. Proteomics 17, 1700180 (2017).","DOI":"10.1002\/pmic.201700180"},{"key":"310_CR107","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold, M. E. et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol. 12, 452\u2013458 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"310_CR108","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/cbic.201300748","volume":"15","author":"R Dai","year":"2014","unstructured":"Dai, R., Wilson, D. J., Geders, T. W., Aldrich, C. C. & Finzel, B. C. Inhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazides. Chembiochem. 15, 575\u2013586 (2014).","journal-title":"Chembiochem."},{"key":"310_CR109","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1742-4658.2009.06912.x","volume":"276","author":"HM Botelho","year":"2009","unstructured":"Botelho, H. M., Koch, M., Fritz, G. & Gomes, C. M. Metal ions modulate the folding and stability of the tumor suppressor protein S100A2. The FEBS J. 276, 1776\u20131786 (2009).","journal-title":"The FEBS J."},{"key":"310_CR110","unstructured":"Miettinen, T. P. et al. Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4\/6 inhibitor palbociclib. EMBO J. 37, e98359 (2018)."},{"key":"310_CR111","doi-asserted-by":"publisher","first-page":"e8242","DOI":"10.15252\/msb.20188242","volume":"14","author":"A Mateus","year":"2018","unstructured":"Mateus, A. et al. Thermal proteome profiling in bacteria: probing protein state in vivo. Mol. Syst. Biol. 14, e8242 (2018).","journal-title":"Mol. Syst. Biol."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41596-020-0310-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41596-020-0310-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41596-020-0310-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:30:17Z","timestamp":1684607417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41596-020-0310-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1038\/s41596-020-0310-z","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.N. is the cofounder and a member of the board of directors of Pelago Bioscience AB and an inventor on a patent series originating from PTC\/GB2012\/050853, held by Pelago Bioscience AB, which covers MS-CETSA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}